Schedule of Changes in Stockholders’ Equity |
The following tables present changes in stockholders’ equity for the nine-month periods ended September 30, 2023 and 2022 (in thousands, except share data):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Additional |
|
|
Accumulated Other |
|
|
|
|
|
Total |
|
|
Common |
|
|
Paid-In |
|
|
Comprehensive |
|
|
Accumulated |
|
|
Stockholders’ |
|
|
Shares |
|
|
Amount |
|
|
Capital |
|
|
Loss |
|
|
Deficit |
|
|
Equity |
|
Balance at December 31, 2022 |
|
87,103,007 |
|
|
$ |
9 |
|
|
$ |
2,420,223 |
|
|
$ |
(7,461 |
) |
|
$ |
(1,177,187 |
) |
|
$ |
1,235,584 |
|
Issuance of common stock through at-the-market offerings, net of issuance costs of $62 |
|
35,349 |
|
|
|
- |
|
|
|
1,466 |
|
|
|
- |
|
|
|
- |
|
|
|
1,466 |
|
Contingent consideration paid to Rewrite Holders |
|
567,045 |
|
|
|
- |
|
|
|
24,126 |
|
|
|
- |
|
|
|
- |
|
|
|
24,126 |
|
Exercise of stock options |
|
48,353 |
|
|
|
- |
|
|
|
755 |
|
|
|
- |
|
|
|
- |
|
|
|
755 |
|
Vesting of restricted stock units |
|
342,025 |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
Equity-based compensation |
|
- |
|
|
|
- |
|
|
|
27,255 |
|
|
|
- |
|
|
|
- |
|
|
|
27,255 |
|
Other comprehensive loss - unrealized gain on marketable securities |
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
2,989 |
|
|
|
- |
|
|
|
2,989 |
|
Other comprehensive loss - equity method investment |
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
1,794 |
|
|
|
- |
|
|
|
1,794 |
|
Net loss |
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
|
|
|
(103,126 |
) |
|
|
(103,126 |
) |
Balance at March 31, 2023 |
|
88,095,779 |
|
|
|
9 |
|
|
|
2,473,825 |
|
|
|
(2,678 |
) |
|
|
(1,280,313 |
) |
|
|
1,190,843 |
|
Exercise of stock options |
|
30,371 |
|
|
|
- |
|
|
|
465 |
|
|
|
- |
|
|
|
- |
|
|
|
465 |
|
Vesting of restricted stock units |
|
151,853 |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
Issuance of shares under employee stock purchase plan |
|
69,631 |
|
|
|
- |
|
|
|
2,051 |
|
|
|
- |
|
|
|
- |
|
|
|
2,051 |
|
Equity-based compensation |
|
- |
|
|
|
- |
|
|
|
36,400 |
|
|
|
- |
|
|
|
- |
|
|
|
36,400 |
|
Other comprehensive loss - unrealized loss on marketable securities |
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
(1,482 |
) |
|
|
- |
|
|
|
(1,482 |
) |
Other comprehensive loss - equity method investment |
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
292 |
|
|
|
- |
|
|
|
292 |
|
Net loss |
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
(123,681 |
) |
|
|
(123,681 |
) |
Balance at June 30, 2023 |
|
88,347,634 |
|
|
|
9 |
|
|
|
2,512,741 |
|
|
|
(3,868 |
) |
|
|
(1,403,994 |
) |
|
|
1,104,888 |
|
Issuance of common stock through at-the-market offerings, net of issuance costs of $81 |
|
405,332 |
|
|
|
- |
|
|
|
14,718 |
|
|
|
- |
|
|
|
- |
|
|
|
14,718 |
|
Exercise of stock options |
|
241,123 |
|
|
|
- |
|
|
|
4,384 |
|
|
|
- |
|
|
|
- |
|
|
|
4,384 |
|
Vesting of restricted stock units |
|
103,732 |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity-based compensation |
|
- |
|
|
|
- |
|
|
|
35,352 |
|
|
|
- |
|
|
|
- |
|
|
|
35,352 |
|
Other comprehensive loss - unrealized gain on marketable securities |
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
142 |
|
|
|
- |
|
|
|
142 |
|
Other comprehensive loss - equity method investment |
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
154 |
|
|
|
- |
|
|
|
154 |
|
Net loss |
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
(122,224 |
) |
|
|
(122,224 |
) |
Balance at September 30, 2023 |
|
89,097,821 |
|
|
$ |
9 |
|
|
$ |
2,567,195 |
|
|
$ |
(3,572 |
) |
|
$ |
(1,526,218 |
) |
|
$ |
1,037,414 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Additional |
|
|
Accumulated Other |
|
|
|
|
|
Total |
|
|
Common |
|
|
Paid-In |
|
|
Comprehensive |
|
|
Accumulated |
|
|
Stockholders’ |
|
|
Shares |
|
|
Amount |
|
|
Capital |
|
|
Loss |
|
|
Deficit |
|
|
Equity |
|
Balance at December 31, 2021 |
|
74,485,883 |
|
|
$ |
7 |
|
|
$ |
1,745,870 |
|
|
$ |
(2,632 |
) |
|
$ |
(703,001 |
) |
|
$ |
1,040,244 |
|
Issuance of common stock through at-the-market offerings, net of issuance costs of $164 |
|
579,788 |
|
|
|
1 |
|
|
|
38,885 |
|
|
|
- |
|
|
|
- |
|
|
|
38,886 |
|
Exercise of stock options |
|
503,830 |
|
|
|
- |
|
|
|
8,435 |
|
|
|
- |
|
|
|
- |
|
|
|
8,435 |
|
Vesting of restricted stock units |
|
54,666 |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
Equity-based compensation |
|
- |
|
|
|
- |
|
|
|
18,491 |
|
|
|
- |
|
|
|
- |
|
|
|
18,491 |
|
Other comprehensive loss - unrealized loss on marketable securities |
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
(5,128 |
) |
|
|
- |
|
|
|
(5,128 |
) |
Other comprehensive loss - equity method investment |
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
(302 |
) |
|
|
- |
|
|
|
(302 |
) |
Net loss |
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
(146,872 |
) |
|
|
(146,872 |
) |
Balance at March 31, 2022 |
|
75,624,167 |
|
|
|
8 |
|
|
|
1,811,681 |
|
|
|
(8,062 |
) |
|
|
(849,873 |
) |
|
|
953,754 |
|
Exercise of stock options |
|
315,747 |
|
|
|
- |
|
|
|
4,827 |
|
|
|
- |
|
|
|
- |
|
|
|
4,827 |
|
Vesting of restricted stock units |
|
36,515 |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
Issuance of shares under employee stock purchase plan |
|
24,316 |
|
|
|
- |
|
|
|
1,068 |
|
|
|
- |
|
|
|
- |
|
|
|
1,068 |
|
Equity-based compensation |
|
- |
|
|
|
- |
|
|
|
23,068 |
|
|
|
- |
|
|
|
- |
|
|
|
23,068 |
|
Other comprehensive loss - unrealized loss on marketable securities |
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
(932 |
) |
|
|
- |
|
|
|
(932 |
) |
Other comprehensive loss - equity method investment |
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
(560 |
) |
|
|
- |
|
|
|
(560 |
) |
Net loss |
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
(100,678 |
) |
|
|
(100,678 |
) |
Balance at June 30, 2022 |
|
76,000,745 |
|
|
|
8 |
|
|
|
1,840,644 |
|
|
|
(9,554 |
) |
|
|
(950,551 |
) |
|
|
880,547 |
|
Issuance of common stock through at-the-market offerings, net of issuance costs of $54 |
|
553,204 |
|
|
|
- |
|
|
|
31,510 |
|
|
|
- |
|
|
|
- |
|
|
|
31,510 |
|
Exercise of stock options |
|
33,336 |
|
|
|
- |
|
|
|
722 |
|
|
|
- |
|
|
|
- |
|
|
|
722 |
|
Vesting of restricted stock units |
|
662 |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
Equity-based compensation |
|
- |
|
|
|
- |
|
|
|
25,215 |
|
|
|
- |
|
|
|
- |
|
|
|
25,215 |
|
Other comprehensive loss - unrealized gain on marketable securities |
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
991 |
|
|
|
- |
|
|
|
991 |
|
Other comprehensive loss - equity method investment |
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
(805 |
) |
|
|
- |
|
|
|
(805 |
) |
Net loss |
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
(113,229 |
) |
|
|
(113,229 |
) |
Balance at September 30, 2022 |
|
76,587,947 |
|
|
$ |
8 |
|
|
$ |
1,898,091 |
|
|
$ |
(9,368 |
) |
|
$ |
(1,063,780 |
) |
|
$ |
824,951 |
|
|